PHARMACOLOGY RESEARCH SERVICES
Cardiomedex’s extensive expertise is at your disposal to support research on preclinical pharmacology. We help our customers to evaluate the effects of drugs and nutritional factors in the field of cardiovascular diseases and cardiometabolic complications.
Physio-pathological models
for in vivo studies
In vivo functional
exploration platform
In vitro / Ex vivo
assays
Molecular screening
(BRET-based technology)
CRO SERVICES FOR ACCELERATED DRUG DISCOVERY AND PRECLINICAL DEVELOPMENT PROCESSES
Our R&D programs aim to develop new models for pathologies lacking effective treatment such as heart failure with preserved ejection fraction (HFpEF) and to increase translational potential by combining concomitant risk factors (diabetes, obesity and liver fibrosis and systemic inflammation leading to myocardial and vascular complications…).
The wide variety of services within our cutting-edge technical platform range from gold standard integrated patho-physiological models to isolated organs and cells.
Our studies are completely customized to comply with client specifications and to provide in-depth functional characterization with biomarker measurements, gene pattern expression and histology assessment.
CONTACT US FOR MORE INFORMATION